Prosecution Insights
Last updated: August 14, 2026
Application No. 18/392,196

DIALYSIS SYSTEM HAVING PUMP ACTUATOR POSITION DETECTION

Non-Final OA §102§103§112
Filed
Dec 21, 2023
Examiner
KIM, SUN U
Art Unit
1777
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Vantive Health GmbH
OA Round
1 (Non-Final)
79%
Grant Probability
Favorable
1-2
OA Rounds
1m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
764 granted / 972 resolved
+13.6% vs TC avg
Moderate +11% lift
Without
With
+11.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
41 currently pending
Career history
1007
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
45.2%
+5.2% vs TC avg
§102
23.9%
-16.1% vs TC avg
§112
19.2%
-20.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 972 resolved cases

Office Action

§102 §103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Species II (claims 3-5, 14) in the reply filed on 7/15/2026 is acknowledged. Claims 2, 6-13 and 15-18 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected species, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 7/15/2026. Specification The disclosure is objected to because of the following informalities: -Paragraph [0048}, Line 13: “FIGURES” should be corrected to “DRAWINGS”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claim 1 is rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor regards as the invention. Claim 1, Line 8 as two conditional “when” clauses which are indefinite as to which condition is being claimed. For examination purpose, “when desired to stop the PD fluid pump” is read as “to stop the PD fluid pump”. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim 14 is rejected under 35 U.S.C. 102(a)(1)/102(a)(2) as being anticipated by US 2015/0057601 A1 to Ly et al. (hereinafter “Ly”). Ly discloses (see Figure 3; paragraphs 0076-0079, 0110-0115, 0130-0138) a peritoneal dialysis (PD) system comprising: a PD fluid pump including a reciprocating member (piston: 133A, 133B) having a home position (see paragraph 0076); at least one pressure sensor (151A, 151B) positioned and arranged along an open fluid line to sense the pressure of PD fluid pumped by the PD fluid pump, wherein the pressure of PD fluid changes in a pattern according to movement of the reciprocating member; and a control unit (139) configured to detect the position (including the home position) of the pump piston using data from a pressure sensor and to stop the pump when required (see paragraphs 0076-0079). Furthermore, the control unit is configured to use a feature in (implicit) the pattern to determine when the reciprocating member is in the home position (see paragraphs 0076-0079). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1 and 3-4 are rejected under 35 U.S.C. 103 as being unpatentable over Ly. Regarding claim 1, Ly discloses (see Figure 3; paragraphs 0076-0079, 0110-0115, 0130-0138) a peritoneal dialysis (PD) system comprising: a PD fluid pump including a reciprocating member (piston: 133A, 133B) having a home position (see paragraph 0076); at least one pressure sensor (151A, 151B) positioned and arranged along an open fluid line to sense the pressure of PD fluid pumped by the PD fluid pump, wherein the pressure of PD fluid changes in a pattern according to movement of the reciprocating member; and a control unit (139) configured to detect the position (including the home position) of the pump piston using data from a pressure sensor and to stop the pump when required (see paragraphs 0076-0079). Furthermore, the control unit is configured to use a feature in (implicit) the pattern to determine when the reciprocating member is in the home position (see paragraphs 0076-0079). Claim 1 differs from Ly in reciting the control unit configured "to stop the PD fluid pump when the reciprocating member is in the home position”. Although Ly does not directly and unambiguously disclose that the control unit is configured to stop the PD fluid pump when the reciprocating member is in the home position, Ly teaches that the control unit is configured to control the pump actuation and that this is directly dependent on the position of the pump piston that has been detected (see paragraphs 0076-0079; paragraph [0077]: “When the pump chamber 138A, 138B has been isolated… the pressure sensors 151A, 151B detects the reference pressure (e.g. 300 mbar), which is indicative of liquid (rather than air) being pressurized within the pump chamber 138A, 138B , the control unit 139 determines the position of the piston 133A, 133B that corresponds to that pressure”). Hence, it would have been obvious to a person of ordinary skill in the art to modify the PD system of Ly to stop the PD fluid pump when the reciprocating member is in the home position to accurately determine the theoretical volume of dialysate in the pump chambers (see paragraph 0078). Regarding claim 3, Ly discloses that the at least one pressure sensor (151A, 151B) is positioned and arranged to take the pressure of PD fluid along an open fluid line, wherein the pressure of PD fluid changes in a pattern according to movement of the reciprocating member, and wherein a feature in the pattern is related the home position (see Figure 3; paragraphs 0076-0079). Regarding claim 4, Ly discloses that the open fluid line is used during a PD treatment, the at least one pressure sensor (151A, 151B) taking the pressure of PD fluid during the PD treatment (see Figure 3; paragraphs 0076-0079). Claim 5 is rejected under 35 U.S.C. 103 as being unpatentable over Ly as applied to claim 1 above, and further in view of US 2024/0197973 A1 to Pettersson et al. (hereinafter “Pettersson”). Ly discloses the PD system as described above and further discloses that the control unit (139) is connected to the pressure sensors (151A, 151B) to the stepper motors (e.g., the drivers of the stepper motors) that drives the pistons (133A, 133B) and to the encoders that monitor rotation of the lead screws of the stepper motors such that the control unit 139 can receive signals from and transmit signals to those components of the system (see paragraph 0076). Claim 5 differs from Ly in reciting that the control unit is configured to take PD fluid pressure readings from the at least one pressure sensor at a sample rate of 50 to 500 Hz. Pettersson discloses PD system comprising one or more pressure sensors located to sense the PD fluid pressure in the used PD fluid lumen of the dual lumen patient line to estimate the PD fluid pressure using an output provided by a driver of a motor that is used to drive the PD fluid pump (see paragraph 0018) wherein the controller e.g., processor is configured to receive a plurality of output signals at a specified rate between 50 Hz and 1000 Hz for sampling between 1 and 100 output signals (see paragraphs 0025-0026). In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976). It would have been obvious to one having ordinary skill in the art at the time the invention was made to take PD fluid pressure readings from the at least one pressure sensor at a sample rate of 50 to 500 Hz depending on desired frequency of pressure readings, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art. In re Aller, 105 USPQ 233. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN KIM whose telephone number is (571)272-1142. The examiner can normally be reached Maxi Flex. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, INSUK BULLOCK can be reached at 571-272-5954. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /John Kim/Primary Examiner, Art Unit 1772 JK 8/4/26
Read full office action

Prosecution Timeline

Dec 21, 2023
Application Filed
Aug 06, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702737
DIALYSIS SYSTEM HAVING ENHANCED FEATURES INCLUDING DRIP PREVENTION
3y 1m to grant Granted Aug 11, 2026
Patent 12702733
APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT AND METHOD FOR CALCULATING CALORIC BALANCE IN AN APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT
2y 8m to grant Granted Aug 11, 2026
Patent 12697567
WATER TREATMENT SYSTEM AND METHOD
2y 8m to grant Granted Aug 04, 2026
Patent 12697284
CAPSULE DEVICE WITH AN APERTURE FORMED BY AN OVERLAP OF TWO HALVE-CAPSULE SHELLS
2y 8m to grant Granted Aug 04, 2026
Patent 12691272
VASCULAR ACCESS DEVICE WITH VESSEL ACCOMODATION
3y 2m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
79%
Grant Probability
90%
With Interview (+11.0%)
2y 9m (~1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 972 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month